Granahan Investment Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-707,398
| Closed | -$5.31M | – | 183 |
|
|
2022
Q2 | $5.31M | Sell |
707,398
-881,546
| -55% | -$6.61M | 0.18% | 115 |
|
|
2022
Q1 | $14.5M | Buy |
1,588,944
+350,061
| +28% | +$3.19M | 0.36% | 74 |
|
|
2021
Q4 | $8.7M | Sell |
1,238,883
-155,387
| -11% | -$1.09M | 0.18% | 120 |
|
|
2021
Q3 | $15.9M | Buy |
1,394,270
+6,299
| +0.5% | +$71.8K | 0.3% | 86 |
|
|
2021
Q2 | $22.2M | Buy |
1,387,971
+228,662
| +20% | +$3.66M | 0.41% | 58 |
|
|
2021
Q1 | $20.7M | Buy |
1,159,309
+825,546
| +247% | +$14.8M | 0.44% | 53 |
|
|
2020
Q4 | $4.51M | Buy |
333,763
+232,514
| +230% | +$3.14M | 0.1% | 137 |
|
|
2020
Q3 | $1.19M | Sell |
101,249
-64,245
| -39% | -$756K | 0.04% | 166 |
|
|
2020
Q2 | $2.44M | Buy |
165,494
+47,216
| +40% | +$697K | 0.09% | 144 |
|
|
2020
Q1 | $1.6M | Sell |
118,278
-128,301
| -52% | -$1.73M | 0.09% | 148 |
|
|
2019
Q4 | $5.96M | Sell |
246,579
-6,363
| -3% | -$154K | 0.27% | 84 |
|
|
2019
Q3 | $4.86M | Buy |
252,942
+202,257
| +399% | +$3.89M | 0.27% | 88 |
|
|
2019
Q2 | $1.5M | Buy |
50,685
+16,009
| +46% | +$473K | 0.07% | 156 |
|
|
2019
Q1 | $1.65M | Sell |
34,676
-22,747
| -40% | -$1.08M | 0.09% | 160 |
|
|
2018
Q4 | $2.07M | Buy |
+57,423
| New | +$2.07M | 0.15% | 130 |
|